Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 97 of 108 for:    "Vascular Hemostatic Disease" | "Doxorubicin"

PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00319865
Recruitment Status : Unknown
Verified April 2006 by Korean Multiple Myeloma Working Party.
Recruitment status was:  Recruiting
First Posted : April 27, 2006
Last Update Posted : April 27, 2006
Sponsor:
Collaborator:
Celgene Corporation
Information provided by:
Korean Multiple Myeloma Working Party

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Primary Completion Date : No date given
Study Completion Date : September 2008